ClinicalTrials.gg
WithdrawnNCT06765213Updated Feb 24, 2026

Human Breast Milk's Role in Food Allergy Development

An observational study in Food Allergy in Infants, Food Allergen Sensitisation and Breast Feeding, Exclusive, sponsored by The University of Texas Medical Branch, Galveston. Withdrawn. Open to participants aged 4 Months to 24 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-24.

Sponsored by The University of Texas Medical Branch, Galveston · Observational

Why this study was withdrawn
No participants enrolled
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
4 Months to 24 Months
Sex
All
01

Study summary

The goal of this prospective cohort pilot study is to learn about food allergens being passed on in breast milk to breast feeding infants.

The main question[s] it aims to answer are:

  • Will major allergens for milk, egg, and peanut be passed on to infants in breast milk?
  • Will the infants become sensitized to and develop an allergy to the food allergens found in breast milk?
  • Will early introduction interventions prevent the development of these food allergies?

Participants will

  • provide breast milk sample (s) for testing for food allergens
  • Infants will be tested for sensitization via skin prick and blood testing
  • Infants will be challenge with suspected foods to determine allergy and undergo early introduction procedures
Read the detailed description

Recruitment of subjects will be open enrollment pregnant or post-partum women with a personal history of atopic disease such as allergic rhinitis/conjunctivitis, asthma, atopic dermatitis (eczema), and/or food allergy who are exclusively breastfeeding.

Mothers will provide a breastmilk sample(s) for testing of allergens to milk, egg, and wheat. Prior to the introduction of solid foods, infants will need to be tested for sensitization to milk, egg, and wheat via skin prick testing and blood allergy testing.

Infants that are negative for sensitization will undergo introduction of these foods per standard practice. Infants that are positive for sensitization will undergo an office food challenge for those foods that they are sensitized to. A positive food challenge is diagnostic for a food allergy and they will be managed according to standard practice. A negative food challenge means that they are not allergic, and they will undergo early introduction protocols and monitored to continued tolerance.

02

Conditions studied

  • Food Allergy in Infants
  • Food Allergen Sensitisation
  • Breast Feeding, Exclusive
  • Breastmilk Collection

Keywords

  • food allergy
  • breastmilk allergen testing
  • food allergen sensitization
  • cow milk allergy
  • egg allergy
  • wheat allergy
03

In context

Breast Feeding

1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.

Browse Breast Feeding studies →

Lead sponsor

The University of Texas Medical Branch, Galveston is the lead sponsor of 257 studies on the registry; 38 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 26 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Months to 24 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Infants at 4 months of age up to 24 months of age.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Pregnant or post-partum females who plan to exclusively breastfeed and their infants who have completed at least 37 weeks of gestation

    1. These are vulnerable populations
    2. Our study involves breastmilk analysis, which we need postpartum mothers to supply.
    3. (Parent) Testing will be done solely on breastmilk samples, with only potential dietary intervention done to the parent postpartum depending on the outcomes of the infant and breastmilk.
    4. (Infant) In order to determine if allergens in breastmilk play a role in food allergen sensitization, we need to test the infants prior to the introduction of solid foods.
  2. Personal history of atopic disease such as allergic rhinitis/conjunctivitis, asthma, food allergies, and atopic dermatitis
  3. Maternal diet must include hen's egg, cow's milk, and wheat products.

Exclusion criteria

Exclusion Criteria:

  1. No maternal history of atopic disease
  2. Exclusive formula feeding
  3. Maternal diet devoid of hen's egg, cow's milk, or wheat, for example, vegan diets and persons with gluten sensitivity.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Breastmilk positive/Infant sensitized

    This group is for infants whose mother's breastmilk is found to be positive for allergens to either cow milk, egg, and/or wheat and who are found to be sensitized to one or more of these allergens.

    Diagnostic Test: Open Ended Oral Food Challenge

  • Breastmilk positive/Infant not sensitized

    This group is for infants whose mother's breastmilk is found to be positive for allergens to either cow milk, egg, and/or wheat and who are found to be not sensitized to the three allergens.

    Other: Early Introduction

  • Breastmilk negative/Infant sensitized

    This group is for infants whose mother's breastmilk is found to be negative for allergens to either cow milk, egg, and/or wheat and who are found to be sensitized to one or more of these allergens.

    Diagnostic Test: Open Ended Oral Food Challenge

  • Breastmilk negative/Infant not sensitized

    This group is for infants whose mother's breastmilk is found to be negative for allergens to either cow milk, egg, and/or wheat and who are found to be not sensitized to the three allergens.

    Other: Early Introduction

Interventions

  • Diagnostic testOpen Ended Oral Food Challenge

    Allergens determined to be sensitized will be brought in for an oral challenge to that food.

  • OtherEarly Introduction

    Infants that are not sensitized will have the food introduced to their diet at regular intervals.

06

What researchers measure

Primary outcomes

  1. To assess the detection of allergens in human breast milk

    A mass spectrometry will be used to detect the allergens. Mass spectrometry is a technique used in the University of Texas Medical Branch (UTMB) laboratory to detect allergens.

    Time frame: Baseline (4 months of age)

  2. To assess breast milk's role in sensitization to allergens

    The infant will be skin prick tested for allergens to milk, eggs, and wheat at 4 months, which is the baseline.

    Time frame: Baseline (4 months of age)

Secondary outcomes

  1. Number of non-sensitized participants

    The infants that are non-sensitized will begin consuming milk, eggs, and wheat, and each well child check visit.

    Time frame: Baseline (4 months of age), 12 months of age, 24 months of age

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2024 to primary completion in Feb 2026, 23 months.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 23, 2024
First posted
Jan 9, 2025
StartActual
Mar 8, 2024
Primary completionActual
Feb 19, 2026
CompletionActual
Feb 19, 2026
Last update
Feb 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06765213
Collaborators
Texas Allergy, Asthma, and Immunology Society
Responsible party
Sponsor
First posted
Jan 9, 2025
Start date
Mar 8, 2024
Primary completion
Feb 19, 2026
Completion
Feb 19, 2026
Last update
Feb 24, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion